IMX-110

· Immix Biopharma Australia Pty Ltd

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for IMX-110, covering 2023-08-08 to 2023-09-28. Get the full timeline:

Most recent: Clinical Trial Update: IMX-110 in Patients With Advanced Solid Tumors [Phase 1, Phase 2]